Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonanceT2* in patients with thalassemia major on various chelation regimens: A 6-year study-Reference-Cited by-同舟云学术

Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonanceT2* in patients with thalassemia major on various chelation regimens: A 6-year study

Published:2013-06-28 Issue:8 Volume:88 Page:652-656
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Ambati Srikanth R.¹,Randolph Rachel E.²,Mennitt Kevin³,Kleinert Dorothy A.²,Weinsaft Jonathan W.⁴,Giardina Patricia J.²

Affiliation:

1. Department of Pediatrics; Memorial Sloan-Kettering Cancer Center; New York; New York

2. Department of Pediatrics; Weill Cornell Medical College; New York; New York

3. Department of Radiology; Weill Cornell Medical College; New York; New York

4. Cardiac MR/CT Imaging Program; Division of Cardiology, Weill Cornell Medical College; New York; New York

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23469/fullpdf

Reference34 articles.

1. Iron in the heart. Etiology and clinical significance;Buja;Am J Med,1971

2. Survival in medically treated patients with homozygous beta-thalassemia;Olivieri;N Engl J Med,1994

3. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance;Anderson;Br J Haematol,2004

4. Quality of life in thalassemia;Telfer;Ann N Y Acad Sci,2005

5. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation;Tanner;J Cardiovasc Magn Reson,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia;Expert Review of Hematology;2024-07-26

2. Cross-sectional study on the impact of cardiac and hepatic iron overload, as measured by MRI T2*, on the quality of life in children with severe beta-thalassemia major;Medicine;2024-07-05

3. Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years;Blood Cells, Molecules, and Diseases;2024-07

4. Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study;Annals of Hematology;2024-03-19

5. Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study;Annals of Hematology;2022-01-05